To determine if CDK7 expression levels were predictive of response to CDK7 inhibition, we measured protein and mRNA gene expression levels of CDK7, HER2 and ER in multiple breast cancer cell lines (Figure 3A and 3B). The gene discussed is ESR1; the disease is breast carcinoma.